Urinary p-nitrophenol as a biomarker of household exposure to methyl parathion. by Hryhorczuk, Daniel O et al.
Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 1041
Methyl parathion (MP) is an organophosphate
insecticide of the phosphorathionate group.
MP is legally restricted to outdoor application
on agricultural crops. From November 1994
to 1997, federal and local environmental and
public health agencies investigated multiple
instances of illegal application of MP in indoor
residences for the purposes of cockroach con-
trol by unlicensed pesticide applicators (Rubin
et al. 2002).
MP is detoxiﬁed by phase II reactions to
p-nitrophenol (PNP) and dimethylphosphate
(ATSDR 2001). Morgan et al. (1977) studied
the elimination kinetics of these two MP
metabolites in four healthy human volunteers
who were exposed orally to low doses of MP.
Urinary excretion of PNP after this oral expo-
sure was rapid, with 86% occurring by 8 hr
postexposure. Urinary PNP has been accepted
as a biologic exposure index for MP by the
American Conference of Governmental
Industrial Hygienists. Urinary PNP has been
used successfully to monitor MP exposure in
agricultural workers (Kahn 1976).
An interagency health sciences steering
committee developed a protocol for investi-
gating and remediating contaminated homes
that was based on a combination of environ-
mental screening for MP contamination
using baseboard wipe sampling and urinary
biomonitoring of household members for
PNP (Clark et al. 2002). The protocol was
refined on the basis of recommendations by
an expert panel (Table 1) (ATSDR 1997).
The biomonitoring protocol consisted of a
single-day A.M. and P.M. spot urine collec-
tion for all household members who agreed
to participate. Action levels for urinary PNP
elevation were age- or high-risk–group spe-
cific and resulted in either relocation, addi-
tional urinary biomonitoring, or no further
action.
The expert panel identiﬁed the variability
in spot samples of urinary PNP (both day to
day and diurnal) as a critical data gap. The
expert panel believed this data gap could be
addressed by measuring the variability of spot
urine PNP samples in a representative sample
of household members of contaminated
homes over a 7-day period. The specific
research questions to be answered in this 
7-day study of urinary PNP biomonitoring
included: How variable and reproducible are
urinary PNPs among individuals living in
MP-contaminated homes? Does adjusting for
urinary creatinine improve the reproducibility
of urinary PNPs under these exposure condi-
tions? How well does a single-day A.M. and
P.M. spot urine collection classify individuals
and households as to their risk category? How
does the probability of making a correct risk
classification for individuals and households
requiring intervention (relocation or addi-
tional monitoring) increase with the number
of samples collected and the number of days
of sampling? Are urinary PNPs correlated
with environmental exposure to MP? Are uri-
nary PNPs correlated with environmental
exposure to PNP?
Materials and Methods
From November 1997 through January
1998, we recruited a convenience sample of
20 households (80 individuals) from a target
population of 473 households (1,999 individ-
uals) in the Chicago, Illinois area identified
by public health authorities as MP contami-
nated and whose members had agreed to par-
ticipate in urinary PNP biomonitoring
(McCann et al. 2002). The selected house-
holds were similar to the target population on
percent renting (60 vs. 60%), percent male
(40 vs. 45%), mean age of household mem-
bers (30.5 vs. 27 years), mean length of resi-
dence (170 vs. 137 months), and geographic
location of residence. The study participants
were asked to participate in a screening pro-
gram that included environmental wipe sam-
pling for MP and PNP, completion of a
household exposure questionnaire, comple-
tion of a daily exposure questionnaire, and
collection of A.M. and P.M. spot urine samples
for PNP on 7 consecutive days. Participants
were recruited after providing informed con-
sent. The study protocol was approved by the
University of Illinois at Chicago Institutional
Review Board.
Residue wipe samples were collected from
various locations (high-contact areas) within
each residence believed to have been treated
with MP. A maximum of nine samples were
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Methyl Parathion
Methyl parathion (MP) is an organophosphate pesticide illegally applied to the interiors of many
hundreds of homes throughout the United States by unlicensed pesticide applicators. Public
health authorities developed a protocol for investigating contaminated homes and classifying their
need for public health interventions. This protocol included environmental screening for MP con-
tamination and 1-day biomonitoring (A.M. and P.M. spot urine samples) of household members for
p-nitrophenol (PNP), a metabolite of MP. The variability of urinary PNP excretion under these
exposure conditions was unknown. We collected A.M. and P.M. spot urine samples for 7 consecu-
tive days from 75 individuals, who were members of 20 MP-contaminated households in the
greater Chicago, Illinois, area, and analyzed them for PNP. We also assessed the ability of the 
1-day sampling protocol to correctly classify exposed individuals and households according to
their need for public health interventions, assuming that 1 week of sampling (14 urinary PNPs)
represented their true exposure condition. The coefficient of variation of log urinary PNPs for
individuals over the course of 7 days of A.M. and P.M. sampling averaged about 15%. Adjusting for
urinary excretion of creatinine improved reproducibility of urinary PNPs among children but not
among adults. The 1-day protocol correctly classiﬁed true risk category in 92% of individuals and
85% of households. The data contained in this study can be used to reﬁne what is already a rea-
sonable and effective approach to identifying MP-exposed households and determining the appro-
priate public health intervention. Key words: biomarker, environmental, methyl parathion,
p-nitrophenol. Environ Health Perspect 110(suppl 6):1041–1046 (2002).
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taken, including the following areas: a
kitchen baseboard, a living room baseboard, a
countertop, and under the kitchen sink. An
average, or BCA (baseboard concentration
average, measured in mcg/cm2), was tabu-
lated for each sampled home. Environmental
area sampling was conducted by the Illinois
Department of Public Health and U.S.
Environmental Protection Agency (U.S. EPA)
field workers in compliance with the U.S.
EPA Region V Pre-Decon Sampling Protocol
(U.S. EPA, 1997). A gauze pad “charged”
with isopropyl alcohol solvent was used to
swipe the designated surface within the cutout
area of a template (10 × 10 cm). The pad was
then placed in a vial marked with the sample
code for that room. The initial environmental
sampling dates ranged from 11 days prior to
the start of a household 7-day biomonitoring
program to 4 days after the initiation of a
household’s biomonitoring program.
Homes were resampled to determine
whether urinary PNP levels may have been
influenced by exposure to environmental
PNP (resulting from the breakdown of the
applied MP). In these homes, resampling for
MP was performed in the same or approxi-
mately the same locations as the first MP
sample collection; in 18 of these homes, sam-
ples for determining environmental PNP lev-
els were collected. This resampling occurred
between 1 and 8 months from the time of
collection of the initial environmental MP
sample. Environmental wipe samples for MP
and PNP were analyzed by the U.S. EPA
using gas chromatography with thermoionic-
specific detection with mass spectroscopy
conﬁrmation.
A household questionnaire and individual
daily questionnaires for every participant for
each of the 7 days were obtained. The house-
hold questionnaire, generally completed with
the head of household present, detailed the
number of occupants, layout of the dwelling,
and description of the areas sprayed. Daily
individual exposure questionnaires were com-
pleted that identified the number of hours,
the individual’s whereabouts, and activity in
the household for 30-min intervals in a 24-hr
period. Activities such as sleeping, reading,
cleaning, watching television, cooking, and
eating were noted, as well as the approximate
time spent for these activities.
Each participant was instructed to
provide two urine samples, one in the morn-
ing and one in the evening, for 7 days.
Participants were encouraged to collect spec-
imens consecutively for 7 days without miss-
ing any days. The ﬁrst day of collection was
chosen randomly by family members.
Participants were instructed not to open the
sterile urine containers before voiding.
Proper hand washing techniques were
encouraged. After a sample was collected,
the participant was instructed to tightly
close the lid, place the container in a plastic
bag, and keep it in a refrigerator or freezer.
Most specimens and individual question-
naires were collected daily or every 2 days, at
the convenience of the head of household.
After urine specimens were collected, they
were placed in a cooler during transporta-
tion and stored in a standard freezer prior to
transfer to the National Center for
Environmental Health Laboratory, U.S.
Centers for Disease Control and Prevention
(CDC) in Atlanta, Georgia. At the time of
transfer, the urine specimens were thawed
for several hours at room temperature.
Urinary PNP was analyzed by the
Nonpersistent Pesticide Laboratory at the
National Center for Environmental Health
Laboratory, CDC (Barr et al. 2002). The
method was as follows: 3 mL urine was spiked
with an isotopically labeled internal standard,
then subjected to an enzyme digestion to liber-
ate PNP from its bound state (glucuronide or
sulfate bound). The hydrolysate was extracted
with dichloromethane, concentrated, then ana-
lyzed by high performance liquid chromatog-
raphy–tandem mass spectrum; 26.9% of PNP
urine samples had PNP values below the
detection limit of 24 ppb. Urinary creatinine
was analyzed by this same laboratory using the
Vitros CREA slide method (Ortho Clinical
Diagnostics, Raritan, NJ, USA).
The variability of urinary PNPs was
determined by measuring each individual’s
mean, standard deviation (SD), and coeffi-
cient of variation (CV) of log10 of their 14
urinary PNPs samples. The data were log
transformed to correct skewness in the dis-
tributions of urinary PNPs. The quartiles of
the distributions of these summary statistics
were reported by time of sampling (A.M./P.M.)
and age group (0–16 and 17 years of age and
older). Reproducibility of urinary PNPs for
individuals was assessed by the intraclass
correlation coefﬁcient (ICC).
The 14 samples of PNP were considered
14 replicates for each person, as the day desig-
nation was arbitrary and its effect was not of
our study interest. The morning/afternoon
samples consisted of seven replicates taken in
the morning (afternoon) of each day. To
reduce the excessive effect, the three largest
observations were replaced by a value a little
greater than the fourth (390); 590–393,
800–396, and 2,000–399. When PNP was
below detection, it was replaced by 12.
Creatinine-adjusted PNP (PNP-A) is the uri-
nary PNP concentration (µg/L) divided by
the creatinine concentration (g/L). Again, to
reduce the excessive effect, the three largest
observations were replaced by a value a little
greater than the fourth largest (480);
610–483, 640–486, and 1,800–489. When
PNP was below detection, it was replaced by
12, and PNP-A was recalculated.
For each individual, their true risk
category was defined as the highest risk
category reached by any one of their 14 spot
urine samples (relocation > biomonitoring >
no further action). For each household, the
true household risk category was defined as
the highest risk category reached by any one
member of the household. The probability of
correctly classifying risk category by day of
sampling or number of samples is simply the
cumulative proportion of individuals (or
households) who had achieved their highest
risk category by that particular day.
Probabilities were calculated only for the sub-
groups that would have required relocation or
monitoring.
A 12-hr time window was created for
every spot urine sample, which consisted of
the 12 hr immediately preceding collection of
the samples. An MP time-exposure variable
(MP-E) was created by multiplying the
household MP-BCA concentration by the
hours spent in the home during the 12-hr
window. A PNP time-exposure variable
(PNP-E) was created by multiplying the
household PNP baseboard concentration
(when available) by the number of hours
spent at home during the 12-hr window.
Spearman rank order correlation coefﬁcients
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Table 1. Action levels for urinary PNP and environmental sampling by age and high-risk group.a
Recommended action No further action Urine monitoring Relocation
Age group
0 – <1 year and pregnant women <25 ppb in urine and 25–50 ppb in urine, or >50 ppb in urine
<50 µg/100 cm2 <25 ppb in urine and
Exposure-based sampling ≥50 µg/100 cm2
Exposure-based sampling
≥1 year – <16 years <100 ppb in urine and 100–300 ppb in urine, or >300 ppb in urine
<50 µg/100 cm2 <100 ppb in urine and
Exposure-based sampling ≥50 µg/100 cm2
Exposure-based sampling
≥16 years <300 ppb in urine and 300–600 ppb in urine, or >600 ppb in urine
<50 µg/100 cm2 <300 ppb in urine and
Exposure-based sampling ≥50 µg/100 cm2
Exposure-based sampling
aAll exposure-based sampling is averaged. All urine numbers are creatinine adjusted; if creatinine numbers are not
available, weight basis will be used.Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 1043
were then calculated to assess the association
between an individual’s urinary PNPs and
these time-weighted exposure variables.
Results
All but one family approached for the MP 
7-day urine collection study agreed to par-
ticipate. Of the remaining 80 individuals
who were scheduled to participate, ﬁve failed
to complete 7-day sampling. Two were
infants who were not able to produce ade-
quate samples for the 7-day study. Seventy-
ﬁve individuals (representing 20 households)
completed the testing. Thirty-nine persons
lived in homes with BCAs below 500
µg/cm2, and 36 lived in dwellings with
BCAs above 500 µg/cm2. Thirty of the 75
participants were male (40%). Household
size ranged from one to nine residents. Over
95% of the households were single homes or
duplexes. The average time since last spray-
ing was 21 months, with a range of 8–62
months. At least one home had been sprayed
more than once. Ages of the participants
ranged from 8 months to 82 years; over one-
third (28) were below the age of 18 years,
including two infants not yet toilet trained.
There were two persons in the age group
0–1 year, 26 persons 2–16 years of age, and
47 persons 17 years of age and older. The
ﬁrst two age groups were combined for later
analysis because the first group included
only two persons. The two age groups 0–16
and 17 years of age and older are also labeled
as youth and adult groups. All adults and
child guardians demonstrated an acceptable
degree of literacy and understanding of
expected procedures prior to the beginning
of the study.
Table 2 presents quartiles for the means,
SDs, and CVs of the log10 of the individuals’
urinary PNP measurements. It is clear from
the CV that variability in adults is greater.
Table 3 presents ICCs and 95%
conﬁdence intervals (CIs) for PNP measures
(adjusted and creatinine adjusted) by age
group under various conditions. All ICCs
except the A.M. replicates for the youth
group were of poor reproducibility. These
results indicate that the reproducibility of
A.M. urinary PNPs for children 0–16 years
of age was good. Reproducibility of P.M.
urinary PNPs in children was poor.
Reproducibility of both A.M. and P.M.
urinary PNPs among adults was poor.
Prior to conducting analyses on PNP-As,
we attempted to determine which demo-
graphic factors were associated with urinary
creatinine excretion. For the youth group, age
was found to be a significant factor but not
sex. For the adult group, sex was found to be
signiﬁcant but not age.
All ICCs for PNP-A for the adult group
were poor. The reproducibility of PNP-As for
the youth group were either in the category of
fair-to-good or excellent, with all values near
the threshold of 0.75. These results indicate
that adjusting for urinary creatinine improved
reproducibility of PNPs among children
0–16 years of age but did not improve repro-
ducibility for those 17 years of age and older.
Although the ICCs of the individual uri-
nary PNPs and PNP-As are generally weak,
the question remains as to how well any indi-
vidual PNP measurement classifies the indi-
vidual as to his or her true risk category. The
three categories of risk are relocation, moni-
toring (additional urine testing), and no risk
(no further action).
Six individuals (four children and two
adults) had urinary PNPs high enough to
trigger relocation. Four of these individuals
(66%) were detected on the ﬁrst day of sam-
pling. Seventeen individuals (14 children and
3 adults) had urinary PNPs high enough to
trigger either relocation or additional moni-
toring. Eleven of these (65%) were detected
on the first day of sampling. Considering
only children 16 years of age and younger,
three of four (75%) with levels high enough
to trigger relocation were detected on the ﬁrst
day of sampling; 11 of 14 children (71%)
with levels high enough to trigger relocation
or additional monitoring were detected on
the ﬁrst day of sampling.
Four homes had at least one individual
with urinary PNPs high enough to trigger
relocation. Three of these homes (75%) were
detected on the ﬁrst day of sampling. Eleven
homes had at least one individual with uri-
nary PNPs high enough to trigger either relo-
cation or additional sampling. Eight of these
homes (73%) were detected on the first day
of sampling.
The cumulative number of new cases
triggering relocation or relocation/monitor-
ing by day of testing is presented in Table 4.
The cumulative probability of detecting
individuals in the relocation risk group by
day of sampling was 0.67 for day 1, 0.83 by
day 2, and 1.0 by day 3. The cumulative
probability of detecting individuals in the
relocation or additional monitoring risk
groups by day of sampling was 0.65 for day
1; 0.76 by day 2; 0.88 by day 3; 0.94 by day
4; and 1.0 by day 5.
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Table 2. Quartiles and range of mean, SD, and CV of 7-day urine PNP (log transformed).
Morning Afternoon
Age group (years) 25th Median 75th Range 25th Median 75th Range
Mean 0–16 1.54 1.73 1.90 0.99 1.49 1.63 1.85 0.90
17+ 1.29 1.53 1.82 1.11 1.31 1.52 1.87 1.06
SD 0–16 0.18 0.22 0.29 0.43 0.19 0.25 0.31 0.38
17+ 0.16 0.22 0.32 0.83 0.16 0.24 0.35 0.62
CV 0–16 9.82 14.07 17.19 21.51 11.06 15.47 19.70 23.58
17+ 9.65 15.87 19.60 56.90 8.43 16.17 23.16 37.65
Table 3. ICC for urine PNP and PNP-A by age group under various conditions.a
Measurement Age group (years) Condition ICCb 95% CI
PNP 0–16 All 7 days 0.39 0.26–0.56
Morning 0.44c 0.29–0.62
Afternoon 0.29 0.16–0.48
1st day only 0.28 0.00–0.59
17+ All 7 days 0.37 0.28–0.50
Morning 0.39 0.27–0.53
Afternoon 0.39 0.28–0.53
1st day only 0.24 0.00–0.49
PNP-A 0–16 All 7 days 0.72c 0.61–0.83
Morning 0.69c 0.56–0.82
Afternoon 0.74c 0.62–0.85
1st day only 0.76d 0.54–0.89
1st 2 days 0.71c 0.56–0.84
1st 3 days 0.75d 0.63–0.86
1st 4 days 0.77d 0.66–0.86
1st 5 days 0.72c 0.60–0.83
1st 6 days 0.71c 0.59–0.82
17+ All 7 days 0.29 0.20–0.41
Morning 0.27 0.17–0.41
Afternoon 0.30 0.19–0.44
1st day only 0.18 0.00–0.44
1st 2 days 0.26 0.12–0.43
1st 3 days 0.26 0.14–0.40
1st 4 days 0.26 0.16–0.39
1st 5 days 0.24 0.15–0.37
1st 6 days 0.27 0.18–0.39
aBoth sexes are combined. The value of PNP below detection (<24) was set to 12. bICC < 0.4 is of poor reproducibility.
c0.4 ≤ ICC ≤ 0.75 = fair to good. dICC ≥ 0.75 = excellent.Although Table 4 provides information
on the cumulative proportion of detected
individuals, it does not directly answer the
question of what is the cumulative probability
of detecting the true risk levels for households
by day of sampling. As households typically
have more than one individual, the probabil-
ity of making a correct classification for the
overall household increases with the number
of individuals in the home. The cumulative
proportions of homes identiﬁed as requiring
relocation or relocation/additional monitor-
ing are presented in Table 5. The cumulative
probability of detecting households in the
relocation risk group by day of sampling was
0.75 for day 1 and 1.0 by day 2. The cumula-
tive probability of detecting households in the
relocation or additional monitoring risk
groups by day of sampling was 0.73 for day 1;
0.82 by day 2; 0.82 by day 3; 0.91 by day 4;
and 1.0 by day 5.
Table 6 presents the numbers of signiﬁcant
correlations between participants’ individual
urinary PNPs and the 12-hr exposures preced-
ing the urine collections, stratified by age
group. For children ages 16 years and younger,
there were no signiﬁcant correlations between
any of their urinary PNP samples and the
time-weighted exposures to MP. There were
several significant correlations between the
children’s urinary PNP samples and their time-
weighted exposure to PNP.
For adults, the situation was reversed.
There were several significant correlations
between their urinary PNP samples and their
time-weighted exposures to MP but relatively
few correlations with their time-weighted
exposures to PNP.
Discussion
An important assumption in the design of the
urinary PNP sampling protocol implemented
was that the variability of spot urine samples
for PNP under these exposure conditions was
sufﬁciently low to permit risk classiﬁcation on
the basis of single-day A.M. and P.M. spot urine
samples. The data collected in this 7-day
study answer this question directly. The CV
for the log10 of an individual’s spot urine
PNPs, given A.M.a nd P.M. sampling over 7
days, averages about 15%. The variability of
spot urine PNPs over a 7-day period is differ-
ent for adults and children. For children 0–16
years of age, the morning samples showed
good intraclass correlation, whereas the after-
noon samples showed poor intraclass correla-
tion. For those 17 years of age and older, the
intraclass correlation among the spot urine
PNPs was consistently poor.
This variability is to be expected, given
that over the course of 7 days, an individual’s
exposure to MP in the home is not homoge-
neous. Factors that inﬂuence the risk of receiv-
ing a dose of MP include environmental,
personal, and behavioral factors. Examples of
environmental factors include variability in
applied MP concentrations at different loca-
tions throughout the home, and variability of
MP concentrations in various media related to
physical factors such as temperature or variable
weeping from absorbed surfaces. Examples of
personal factors include variable wearing of
clothing, variable rates of respiration, variable
concentration of urine, and perhaps variable
rates of metabolism. Examples of behavioral
factors include time spent in the home, degree
of hand-mouth activity, and variable activities
such as crawling, which create opportunities
for skin contact with MP.
The ideal bioassay sample for urinary
PNP would be a 24-hr urine collection and
measurement of the actual amount of PNP
excreted per unit of time. This approach
imposes substantial burden on participants
and is not practical for large-scale
biomonitoring. Another approach is to
measure the concentration of PNP in a spot
urine sample. Because the concentration is
dependent on the volume of urine, this mea-
sure is influenced by the degree of urinary
concentration. A recognized approach to
adjusting for differences in urinary concen-
tration is to adjust PNP excretion by the
amount of simultaneous excretion of creati-
nine, a normal waste product of muscle
metabolism. The expert advisory panel sug-
gested this adjustment as a modification to
the steering committee protocol. Data from
this 7-day study indicate that adjusting for
urinary creatinine had a dramatic effect on
improving intraclass correlation of urinary
PNPs among children. After adjusting for
urinary creatinine, the intraclass correlations
of spot urine PNPs among those 0–17 years
of age were consistently good or excellent.
Adjusting for urinary creatinine did not
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Table 4. Cumulative number of individuals with urinary levels high enough to trigger relocation or reloca-
tion/monitoring by day of testing.
Home requires relocation Requires relocation or monitoring
Day No. new cases Cumulative No. new cases Cumulative
14 4 1 1 1 1
21 5 2 1 3
31 6 2 1 5
40 6 1 1 6
50 6 1 1 7
60 6 0 1 7
70  6 0   1 7
Total 6 17
Table 5. Homes requiring relocation and/or monitoring based on all household members.a
Home requires relocation Requires relocation and/or monitoring
Day No. new cases Cumulative No. new cases Cumulative
13 3 8 8
21 4 1 9
30 4 0 9
40 4 1 1 0
50 4 1 1 1
60 4 0 1 1
70 4 0 1 1
Total 4 11
aTotal number of homes = 20.
Table 6. Relationship between urine sample (PNP, PNP-A) and 12-hr prior environmental exposure (MP-E,
PNP-E).a
A.M. urine sampling day P.M. urine sampling day
Youths, 0–16 years
Urine Environment 2 3 4 5 6 7 1 2 3 4 5 6 7
PNP MP-E – – – – – – – – – – – – –
PNP-A MP-E – – – – – – – – – – – – –
PNP PNP-E – * – * – ** – ** * ** – – –
PNP-A PNP-E – * – – – – * * – – – – *
Adults, 17+ years
Urine Environment 2 3 4 5 6 7 1 2 3 4 5 6 7
PNP MP-E – – – * – – – – – – * – –
PNP-A MP-E – * – * * – – – – – * – –
PNP PNP-E – – – – – – – – – – – – –
PNP-A PNP-E – – – – – – * – – – * – –
aNot all persons started on the same day. Day sequence is an artiﬁcial alignment. No day 1 for A.M. sampling because of
insufﬁcient length of exposure. Spearman rank order correlation: *, positive correlation signiﬁcant at 0.05; **, signiﬁcant
at 0.01; – , not signiﬁcant.improve the intraclass correlation of spot
urine PNPs for adults. The adult intraclass
correlations for creatinine-adjusted spot
urine PNPs were consistently poor.
Although the intraclass correlation of
individual urinary PNPs gives us an index of
the variability of these continuous measures, a
more important question is how well a 1-day
(A.M. and P.M.) sampling strategy classifies
individuals into the appropriate risk cate-
gories (relocation, additional monitoring, or
no action). It is important to note we consid-
ered a person’s true risk category as the high-
est category attained, i.e. relocation >
additional monitoring > no action.
Individuals typically moved between risk cat-
egories over the 7 days of sampling as their
urinary PNPs ﬂuctuated.
The ability of the 1-day protocol (1-day
A.M. and P.M. sampling) to correctly classify
individuals was 92% (69/75). The ability of
the 1-day protocol to identify those individu-
als requiring relocation was 67% (4/6). The
ability of the 1-day protocol to identify those
individuals requiring relocation or monitor-
ing was 65% (11/17). The strategy of A.M.
and P.M. sampling increased the probability
of making a correct determination. Among
children and adults, 6 of the 11 cases detected
on day 1 would have been missed with A.M.
or P.M. sampling alone. The ability of a 1-day
protocol to correctly classify households was
85% (17/20). The ability of the 1-day proto-
col to identify those households requiring
relocation was 75% (3/4). The ability of the
1-day protocol to identify households requir-
ing relocation or additional monitoring was
73% (8/11).
The majority of risk classifications into
intervention categories (relocation or addi-
tional monitoring) occurred on the basis of
urinary sampling results in children. Forty-
four of the 47 adults in the study were classi-
ﬁed in the no-action category on the basis of
all 14 of their individual sampling results.
Two adults (28 and 29 years of age) in a sin-
gle household had urinary PNPs sufficiently
high to warrant relocation (4%). One of these
adults would have been identiﬁed on the basis
of the first day of sampling. The second
would have been identiﬁed only after 3 days
of sampling. One adult 58 years of age in
another home had a urinary PNP sufﬁciently
high to warrant additional biomonitoring.
This person’s risk category would have been
correctly classiﬁed on the basis of the second
day of sampling.
An important finding in this study is the
vast majority of interventions are triggered
by children. This is not surprising, given
that children are a high-risk group for MP
exposure and MP effects and that their
action levels were set lower than those of
adults. Fourteen of the 28 children (50%)
in the study 16 years of age and younger
had urinary PNPs on at least 1 day of sam-
pling that warranted an intervention. Four
children in four homes (14% of the 28 chil-
dren in the study; ages < 1 year, 1 year, 2
years, and 5 years) had levels sufficiently
high to warrant relocation. Eight of 11 chil-
dren (73%) in the age group of 5 years and
younger had levels high enough to warrant
either relocation or additional monitoring.
The ability of a 1-day (A.M. and P.M.)
urine sampling strategy to correctly classify an
individual or household according to their
need for intervention can be directly deter-
mined from this 7-day study. This strategy
has a 0.67 probability of identifying individu-
als who would trigger a relocation and a 0.65
probability of identifying individuals who
would trigger either relocation or additional
monitoring. As households typically have
more than one member, sampling multiple
members of households increases the proba-
bility of identifying homes requiring inter-
vention. The household sizes in the sample
ranged from one to seven, with an average of
3.75. In this study sample, this strategy has a
0.75 probability of identifying a household
requiring relocation and a 0.73 probability of
identifying a household requiring either relo-
cation or additional monitoring.
In this study sample, the identiﬁcation of
all individuals triggering relocation required
2 days of sampling. The identiﬁcation of all
individuals requiring relocation or additional
monitoring required 5 days of sampling. The
identification of all households requiring
relocation required 2 days of sampling of all
household members. The identiﬁcation of all
households requiring relocation or additional
monitoring required 5 days of sampling. It is
important to recognize that the purpose of
additional monitoring is to identify homes
requiring relocation; in this sample, these
homes all would have been identified with
2d ays of sampling. On the other hand, this
2-day sampling interval for identifying all
homes requiring relocation is based on a very
small number of homes.
The risk of coming into contact with an
MP-contaminated surface clearly increases
with time spent in a contaminated environ-
ment. After MP is absorbed, data from
human volunteer studies indicate it is rapidly
metabolized to PNP, among other metabo-
lites, and most of this PNP is excreted within
the first 12 hr after absorption. Given these
kinetics, we surmised that a spot urinary PNP
most likely reflected exposure that occurred
during the previous 12 hr. We then created a
time-weighted exposure variable (average MP
concentration × time or concentrations
within individual rooms × time) as well as
[average environmental PNP concentration ×
time]) to adjust for these time factors.
Analysis of correlations between urinary
PNPs and time-weighted exposure factors
yielded very interesting results. For children
16 years of age and younger, urinary PNPs or
PNP-A were signiﬁcantly correlated with envi-
ronmental time-weighted PNP exposures on
A.M. or P.M. samples on 6 of the 7 sampling
days. Children’s urinary PNPs were not corre-
lated with environmental time-weighted MP
concentrations on any of the A.M. or P.M. sam-
ples on any of the sampling days. The correla-
tions with environmental PNP as opposed to
environmental MP for children are especially
surprising given the smaller number of obser-
vations for environmental PNP.
For adults, urinary PNPs or PNP-As were
significantly correlated with environmental
time-weighted MP exposures on A.M. or P.M.
samples on 3 of the 7 sampling days. PNP-As
were correlated with environmental time-
weighted PNP exposure for P.M. samples col-
lected on 2 of the 7 sampling days.
These results suggest that for children,
the group that triggers most of the household
interventions, urinary PNP concentrations
appear to be associated more with environ-
mental PNP exposure than with environ-
mental MP exposure. For adults, urinary
PNPs appear to be associated with MP expo-
sure and PNP exposure. Important data gaps
preclude reaching beyond these statistical
associations to conclude that urinary PNPs
in children are primarily the result of envi-
ronmental exposure to PNP. Environmental
sampling for PNP was very limited and
included measurements of baseboard con-
centrations in only a subset of the homes.
PNP was not measured on surfaces that chil-
dren were more likely to encounter, such as
toys, carpets, or bedding. The environmen-
tal chemistry of PNP suggests that inhala-
tion is only a minor route of exposure. A
theoretic possibility is that given PNP’s
moderate water solubility, washing base-
boards with water may increase the disper-
sion of PNP to other surfaces in a home.
The best approach, in our opinion, is to
address these issues correctly and include
rigorous sampling of PNP in a sample of
homes undergoing environmental sampling
for MP. Such sampling should include air,
house dust, toys, bedding, and kitchen
counters in addition to baseboard sampling.
Urine monitoring in this sample of homes
should include analysis of not only PNP but
also other MP metabolites (e.g., dimethyl-
phosphate—presuming dimethylphosphate
is not also an environmental degradation
product of MP), which would help deter-
mine the source of the urinary PNP (MP
metabolite vs. environmental PNP).
In summary, the 1-day (A.M. and P.M.)
protocol implemented in the MP public
health remediation effort was effective in
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homes requiring intervention. The provision
of additional surveillance systems such as MP
hotlines, poison control center hotlines, and
clinical evaluations for symptomatic individ-
uals, undoubtedly supplemented the envi-
ronmental investigation/biomonitoring
approach in addressing this large-scale out-
break. The data contained in this report can
be used to reﬁne what is already a reasonable
and effective approach to identifying MP-
exposed households that require public
health interventions.
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